553 related articles for article (PubMed ID: 9107083)
1. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
Vannucchi AM; Bosi A; Linari S; Guidi S; Longo G; Lombardini L; Mariani MP; Saccardi R; Laszlo D; Rossi Ferrini P
Haematologica; 1997; 82(1):53-6. PubMed ID: 9107083
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial.
Vannucchi AM; Bosi A; Ieri A; Guidi S; Saccardi R; Lombardini L; Linari S; Laszlo D; Longo G; Rossi-Ferrini P
Bone Marrow Transplant; 1996 Apr; 17(4):527-31. PubMed ID: 8722349
[TBL] [Abstract][Full Text] [Related]
3. Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants.
Locatelli F; Zecca M; Pedrazzoli P; Prete L; Quaglini S; Comoli P; De Stefano P; Beguin Y; Robustelli della Cuna G; Severi F
Bone Marrow Transplant; 1994 Apr; 13(4):403-10. PubMed ID: 8019464
[TBL] [Abstract][Full Text] [Related]
4. Circulating CFU-E during hematopoietic recovery after allogeneic bone marrow transplantation: relationship to erythroid engraftment.
Vannucchi AM; Bosi A; Lombardini L; Grossi A; Bacci P; Guidi S; Saccardi R; Rossi-Ferrini P
Exp Hematol; 1995 Dec; 23(13):1337-40. PubMed ID: 7498360
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of erythroid engraftment by recombinant human erythropoietin in ABO-compatible, HLA-identical, allogeneic bone marrow transplant patients.
Vannucchi AM; Bosi A; Grossi A; Guidi S; Saccardi R; Lombardini L; Rossi-Ferrini P
Leukemia; 1992 Mar; 6(3):215-9. PubMed ID: 1564959
[TBL] [Abstract][Full Text] [Related]
6. Pilot trial of combined administration of erythropoietin and granulocyte colony-stimulating factor to children undergoing allogeneic bone marrow transplantation.
Locatelli F; Zecca M; Ponchio L; Beguin Y; Giorgiani G; Maccario R; Bonetti F; De Stefano P; Cazzola M
Bone Marrow Transplant; 1994 Dec; 14(6):929-35. PubMed ID: 7536073
[TBL] [Abstract][Full Text] [Related]
7. Reduced blood transfusions requirements after allogeneic bone marrow transplantation: results of a randomised, double-blind study with high-dose erythropoietin.
Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
Bone Marrow Transplant; 1994 Apr; 13(4):397-402. PubMed ID: 8019463
[TBL] [Abstract][Full Text] [Related]
8. Prospective randomised double-blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA-identical sibling donors. The Australian Bone Marrow Transplant Study Group.
Biggs JC; Atkinson KA; Booker V; Concannon A; Dart GW; Dodds A; Downs K; Szer J; Turner J; Worthington R
Bone Marrow Transplant; 1995 Jan; 15(1):129-34. PubMed ID: 7742745
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants.
Beguin Y; Oris R; Fillet G
Bone Marrow Transplant; 1993 Apr; 11(4):285-92. PubMed ID: 8485476
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin treatment in allogeneic BMT accelerates erythroid reconstitution: results of a prospective controlled randomized trial.
Steegmann JL; López J; Otero MJ; Lamana ML; de la Cámara R; Berberana M; Díaz A; Fernández-Rañada JM
Bone Marrow Transplant; 1992 Dec; 10(6):541-6. PubMed ID: 1490203
[TBL] [Abstract][Full Text] [Related]
11. Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation.
Beguin Y; Baron F; Fillet G
Haematologica; 1998 Dec; 83(12):1076-81. PubMed ID: 9949624
[TBL] [Abstract][Full Text] [Related]
12. Serum erythropoietin levels and blood component therapy after autologous bone marrow transplantation: implications for erythropoietin therapy in this setting.
Lazarus HM; Goodnough LT; Goldwasser E; Long G; Arnold JL; Strohl KP
Bone Marrow Transplant; 1992 Jul; 10(1):71-5. PubMed ID: 1515882
[TBL] [Abstract][Full Text] [Related]
13. Improvement of thrombocytopenia following bone marrow transplantation by pegylated recombinant human megakaryocyte growth and development factor in mice.
Kabaya K; Shibuya K; Torii Y; Nitta Y; Ida M; Akahori H; Kato T; Kusaka M; Miyazaki H
Bone Marrow Transplant; 1996 Dec; 18(6):1035-41. PubMed ID: 8971370
[TBL] [Abstract][Full Text] [Related]
14. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
15. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
16. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of recombinant human granulocyte colony-stimulating factor in children undergoing bone marrow transplantation.
Dini G; Floris R; Pession A; Manfredini L; Dallorso S; Lanino E; Garaventa A; Miano M; Kotitsa Z; Rondelli R
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():121-8. PubMed ID: 8932813
[TBL] [Abstract][Full Text] [Related]
18. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
[TBL] [Abstract][Full Text] [Related]
20. Early treatment of premature infants with recombinant human erythropoietin.
Messer J; Haddad J; Donato L; Astruc D; Matis J
Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
